Mumbai, Sept. 9 -- Ichnos Glenmark Innovation (IGI), Glenmark's wholly owned subsidiary, has received an upfront payment of $700 million from AbbVie (NYSE: ABBV).

Published by HT Digital Content Services with permission from Capital Market....